Your browser doesn't support javascript.
loading
Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.
Hatake, Kiyohiko; Chou, Takaaki; Doi, Toshihiko; Terui, Yasuhito; Kato, Harumi; Hirose, Takayuki; Seo, Sachiko; Pourdehnad, Michael; Ogaki, Yumi; Fujimoto, Hiroshi; Hagner, Patrick R; Yamamoto, Kazuhito.
Affiliation
  • Hatake K; Lymphoma/Hematology Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
  • Chou T; Department of Hematology Oncology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan.
  • Terui Y; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kato H; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Hirose T; Department of Hematology Oncology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Pourdehnad M; Bristol Myers Squibb, Princeton, NJ, USA.
  • Ogaki Y; Celgene K.K., A Bristol Myers Squibb Company, Tokyo, Japan.
  • Fujimoto H; Celgene K.K., A Bristol Myers Squibb Company, Tokyo, Japan.
  • Hagner PR; Bristol Myers Squibb, Princeton, NJ, USA.
  • Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Cancer Sci ; 112(1): 331-338, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33075165

Full text: 1 Database: MEDLINE Main subject: Piperidones / Lymphoma, Non-Hodgkin / Esophageal Neoplasms / Quinazolinones / Antineoplastic Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Sci Year: 2021 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Piperidones / Lymphoma, Non-Hodgkin / Esophageal Neoplasms / Quinazolinones / Antineoplastic Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Sci Year: 2021 Type: Article Affiliation country: Japan